Cargando…

Field-Based Flow Cytometry for Ex Vivo Characterization of Plasmodium vivax and P. falciparum Antimalarial Sensitivity

Ex vivo antimalarial sensitivity testing in human malaria parasites has largely depended on microscopic determination of schizont maturation. While this microscopic method is sensitive, it suffers from poor precision and is laborious. The recent development of portable, low-cost cytometers has allow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, B., Malleret, B., Suwanarusk, R., Anthony, C., Kanlaya, S., Lau, Y. L., Woodrow, C. J., Nosten, F., Renia, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2013
Materias:	Susceptibility
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811473/ https://www.ncbi.nlm.nih.gov/pubmed/23877705 http://dx.doi.org/10.1128/AAC.00682-13

Ejemplares similares

Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes
por: Wirjanata, Grennady, et al.
Publicado: (2017)

Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs
por: Yipsirimetee, Achaporn, et al.
Publicado: (2023)

Comparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field Conditions
por: Woodrow, Charles J., et al.
Publicado: (2015)

Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by Ex Vivo Parasite Survival Rate Assay
por: Mbye, Haddijatou, et al.
Publicado: (2020)

Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014)

Inhibitory Compounds Targeting Plasmodium falciparum Gyrase B
por: Pakosz, Zuzanna, et al.
Publicado: (2021)

Decreased In Vitro Artemisinin Sensitivity of Plasmodium falciparum across India
por: Chakrabarti, Rimi, et al.
Publicado: (2019)

A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax
por: Russell, Bruce, et al.
Publicado: (2011)

A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development
por: Malleret, Benoît, et al.
Publicado: (2011)

A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action
por: Hendon-Dunn, Charlotte Louise, et al.
Publicado: (2016)

Therapeutic disruption of Plasmodium vivax infected red cell deformability
por: Zhang, Rou, et al.
Publicado: (2014)

Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development
por: Bancone, Germana, et al.
Publicado: (2017)

Methotrexate Is Highly Potent Against Pyrimethamine-Resistant Plasmodium vivax
por: Imwong, Mallika, et al.
Publicado: (2011)

Gametocytes from K13 Propeller Mutant Plasmodium falciparum Clinical Isolates Demonstrate Reduced Susceptibility to Dihydroartemisinin in the Male Gamete Exflagellation Inhibition Assay
por: Lozano, Sonia, et al.
Publicado: (2018)

Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood
por: Sriprawat, Kanlaya, et al.
Publicado: (2009)

Rheopathologic Consequence of Plasmodium vivax Rosette Formation
por: Zhang, Rou, et al.
Publicado: (2016)

Plasmodium vivax trophozoites insensitive to chloroquine
por: Sharrock, Wesley W, et al.
Publicado: (2008)

Rosetting Responses of Plasmodium-infected Erythrocytes to Antimalarials
por: Lee, Wenn-Chyau, et al.
Publicado: (2022)

Recent Molecular Assessment of Plasmodium vivax and Plasmodium falciparum Asymptomatic Infections in Botswana
por: Motshoge, Thato, et al.
Publicado: (2021)

Plasmodium falciparum rosetting protects schizonts against artemisinin
por: Lee, Wenn-Chyau, et al.
Publicado: (2021)

Comparison of three molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparum
por: Boonma, Prapaporn, et al.
Publicado: (2007)

Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests
por: Ardizzoni, E., et al.
Publicado: (2021)

Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation
por: Keating, Claire L., et al.
Publicado: (2021)

Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection
por: Price, Bianca L., et al.
Publicado: (2016)

Genetic Diversity in New Members of the Reticulocyte Binding Protein Family in Thai Plasmodium vivax Isolates
por: Kosaisavee, Varakorn, et al.
Publicado: (2012)

XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus
por: Ledger, Elizabeth V. K., et al.
Publicado: (2023)

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates
por: Goldstein, Ellie J. C., et al.
Publicado: (2013)

Correction: Genetic Diversity in New Members of the Reticulocyte Binding Protein Family in Thai Plasmodium vivax Isolates
por: Kosaisavee, Varakorn, et al.
Publicado: (2012)

Derepression of the smvA Efflux System Arises in Clinical Isolates of Proteus mirabilis and Reduces Susceptibility to Chlorhexidine and Other Biocides
por: Pelling, H., et al.
Publicado: (2019)

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against 162 Strains from 35 Less Frequently Recovered Intestinal Clostridium Species: Implications for Clostridium difficile Recurrence
por: Goldstein, Ellie J. C., et al.
Publicado: (2014)

A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020–2021
por: Snydman, D. R., et al.
Publicado: (2023)

Biocide Exposure Induces Changes in Susceptibility, Pathogenicity, and Biofilm Formation in Uropathogenic Escherichia coli
por: Henly, E. L., et al.
Publicado: (2019)

Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery
por: Duffy, Sandra, et al.
Publicado: (2017)

Regrowth of Mycobacterium tuberculosis Populations Exposed to Antibiotic Combinations Is Due to the Presence of Isoniazid and Not Bacterial Growth Rate
por: Hendon-Dunn, Charlotte L., et al.
Publicado: (2019)

Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics
por: Douglas, Nicholas M., et al.
Publicado: (2011)

Bloodstream Infections Caused by Magnusiomyces capitatus and Magnusiomyces clavatus: Epidemiological, Clinical, and Microbiological Features of Two Emerging Yeast Species
por: Noster, Janina, et al.
Publicado: (2022)

Transient and Sustained Bacterial Adaptation following Repeated Sublethal Exposure to Microbicides and a Novel Human Antimicrobial Peptide
por: Forbes, Sarah, et al.
Publicado: (2014)

Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals during 2016 to 2018
por: Castanheira, Mariana, et al.
Publicado: (2020)

Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis
por: Ghannoum, M., et al.
Publicado: (2018)

Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients
por: Reichmuth, Martina L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hjuphpm30s89td06rrq0lh0qd1